Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

FlexDex

Explore full profile

An innovative medical device company based in Michigan, with a passion for bringing cutting edge technology from an idea into reality

Brighton Township, United StatesFounded 2010Biotech & Life Sciences
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for FlexDex and the history behind them.

About FlexDex

FlexDex Surgical is a medical device company focused on developing a platform of advanced laparoscopic instruments. Founded in 2010 by University of Michigan Associate Professor Shorya Awtar, pediatric surgeon Dr. James Geiger, and Greg Bowles, the company was spun out of the university to commercialize its technology. The founders' expertise in mechanical engineering and surgery underpins the company's core mission: to provide surgeons with instruments that mimic the dexterity and intuitive control of robotic surgery but in a purely mechanical, more affordable format.

The company operates in the minimally invasive surgery (MIS) market, serving surgeons and hospitals. Its business model centers on selling these specialized surgical devices directly to healthcare institutions. By offering a cost-effective alternative to multi-million dollar robotic systems, FlexDex aims to expand access to the benefits of advanced MIS, such as reduced patient pain and faster recovery times, to a broader range of hospitals and procedures. The company has secured significant funding to support its development and commercialization efforts, raising a total of $45.4 million over 13 rounds, with notable investors including Johnson & Johnson Innovation and Almeda Ventures.

FlexDex's core product is a platform of surgeon-powered, wristed laparoscopic instruments. The flagship device, the AXIUS™ Needle Driver, is designed for complex suturing and knot-tying during MIS procedures. Its patented "Virtual Center" technology translates the surgeon's hand, wrist, and arm movements into corresponding, precise movements of the instrument's tip inside the patient's body. This purely mechanical system provides surgeons with enhanced dexterity, 360-degree rotation, and natural force feedback without the capital expense and complexity of a robotic system. The AXIUS™ Needle Driver, which is FDA registered, has been designed to be reprocessed multiple times, enhancing its cost-efficiency for hospitals. The company is expanding this platform to a full suite of advanced laparoscopic tools.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
Brighton Township, United States
Employees
16
Open positions
None listed
Dealroom signal
61.1/100
Industry
Health
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Biotechnology, Surgery, Non-Invasive medical devices and treatments, Spinout, Medical Robots, Collaborative Robots, Surgical Robots, DT and LS
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

8 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Dec 2024 $2M $73M Undisclosed —
SERIES A✓Equity / VC Aug 2021 $13M $73M Almeda Ventures · Johnson & Johnson Innovation —
Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

FlexDex website traffic

Latest recorded traffic for FlexDex is 1K monthly website visits, up 809.1% over the last three months. FlexDex's team grew 0% over the past year.

Latest monthly visits1K 3-month web change+809.1% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • US National Science Foundation

Series A2 investors entered at this stage

  • Almeda Ventures
  • Johnson & Johnson Innovation

Other known investors2 additional known investors

  • University of Michigan
  • Michigan Biomedical Venture Fund
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about FlexDex on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See FlexDex’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.